Literature DB >> 26225331

An atypical presentation of antiphospholipid antibody syndrome.

Deepti D'souza1, Sukumar Dandakeri1, M Ramesh Bhat1, M K Srinath1.   

Abstract

Cutaneous manifestations in antiphospholipid antibody syndrome (APS) though common, are extremely diverse and it is important to know which dermatological finding should prompt consideration of antiphospholipid syndrome. The cutaneous manifestations of APS vary from livedo reticularis to cutaneous necrosis, and systemic involvement is invariably an accomplice in APS. Cutaneous ulcers with sharp margins can be seen in APS and they are usually seen on the legs. This case had an atypical presentation, as the initial presentation was painful necrotic ulcers over the legs, which resembled pyoderma gangrenosum and she had no systemic manifestations. There was no history of any arterial or venous thrombosis or any abortions. Antiphospholipid syndrome can be tricky to diagnose when cutaneous lesions are atypical. Nonetheless, it is very important to pin down this syndrome early due to its systemic complications.

Entities:  

Keywords:  Anticardiolipin antibody; antiphospholipid antibody syndrome; pyoderma gangrenosum

Year:  2015        PMID: 26225331      PMCID: PMC4513406          DOI: 10.4103/2229-5178.160258

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


INTRODUCTION

The antiphospholipid antibody syndrome (APS) is a prothrombotic condition characterized by the presence of antiphospholipid antibodies in patients with recurrent morbidity during pregnancy and/or thromboembolic complications.[1] The cutaneous manifestations of APS vary from livedo reticularis to cutaneous necrosis. Ulcers resembling pyoderma gangrenosum (PG) have been described in APS and may cause confusion in diagnosis. It is important to be knowledgeable about APS as they can provide crucial information to uncover or confirm APS, and early diagnosis will spare patients from more serious consequences of the disease.[2]

CASE REPORT

A 31 year old female presented with painful ulcers over legs since one month. The lesions initially occurred as painful hemorrhagic bullae, which broke to form exquisitely tender necrotic ulcers that had violaceous indurated borders [Figure 1]. Reddish painful lesions over the face and ears, pus-filled lesions over elbows, and bluish discoloration of a few digits were noted. She was also febrile and in poor general condition. Three months ago, she had transient loss of vision that lasted three days. There was no history of any precipitating factors, drug intake, chronic disease, peripheral vascular disease, or abortions. She had five children with no obstetric complications. However, the third delivery was a preterm delivery. We considered PG, ecthyma gangrenosum, and SLE. Investigations revealed elevated total leukocyte count, platelet count, erythrocyte sedimentation rate, and alkaline phosphatase. Activated partial thromboplastin time and prothrombin time were also mildly elevated. International normalized ratio (INR) was normal. Peripheral smear revealed neutrophilic leukocytosis with marked thrombocytosis. Serum electrolytes, renal function tests, chest radiography, ultrasound abdomen, blood culture, and echocardiography were normal. Fundoscopy was normal. Antinuclear antibody profile and pathergy test were negative. Tzanck smear showed neutrophils. Pus for culture and sensitivity showed scanty growth of Staphylococcus aureus. Rheumatoid factor was mildly elevated. Skin biopsy revealed a “sea of neutrophils” in the dermis suggestive of PG [Figure 2]. Staining with Periodic acid Schiff and Gomori methenamine silver stain was negative. Painful ulcers in a young female of child-bearing age prompted us to do further tests such as anticardiolipin antibodies and lupus anticoagulant test. Anticardiolipin antibody IgG, IgM were positive in high titers. The lupus anticoagulant test was positive. In view of the clinical and laboratory findings, we arrived at a final diagnosis of APS [Table 1].
Figure 1

Necrotic ulcers seen over the feet (a) with bluish discoloration of fingers (b), toes (c), and ulceration in the oral mucosa (d)

Figure 2

Low power view 10x showing epidermis with necrosis, diffuse inflammatory infilterate in dermis (a), High power view 40x showing “Sea of neutrophils” in the dermis (b)

Table 1

Clinical criteria for antiphospholipid antibody syndrome

Necrotic ulcers seen over the feet (a) with bluish discoloration of fingers (b), toes (c), and ulceration in the oral mucosa (d) Low power view 10x showing epidermis with necrosis, diffuse inflammatory infilterate in dermis (a), High power view 40x showing “Sea of neutrophils” in the dermis (b) Clinical criteria for antiphospholipid antibody syndrome She was treated with oral warfarin that was gradually increased after monitoring INR. The patient showed good improvement with treatment [Figure 3]. A repeat lupus anticoagulant test after 12 weeks was also positive confirming the diagnosis of APS.
Figure 3

Healed lesions over dorsum of feet (a), Healed lesions over fingers on follow up (b)

Healed lesions over dorsum of feet (a), Healed lesions over fingers on follow up (b)

DISCUSSION

Cutaneous manifestations in APS though common, are extremely diverse. It is important to know which dermatological finding should prompt a consideration of APS. Thrombosis, the main complication of APS, can affect vessels of nearly all sizes including dermal veins or arteries.[3] Cutaneous manifestations of APS include livedo reticularis, subungual splinter hemorrhages, digital necrosis, superficial venous thrombosis, post-phlebitis ulcers, circumscribed cutaneous necrosis, pseudovasculitis manifestations, extensive cutaneous necrosis, and primary anetoderma.[4] Cutaneous ulcers with sharp margins may be seen in APS, usually over the legs. About 40% of the patients have underlying multisystem thrombotic phenomena.[5] Pregnancy morbidity in the form of fetal loss or premature birth is a common finding in women with APS. Treatment includes aspirin, warfarin, and heparin. This patient's presentation was atypical as she presented with painful necrotic ulcers over the legs that resembled PG with a suggestive histopathology. Pyoderma gangrenosum has not been mentioned as a cutaneous finding of APS. However, it is said that this syndrome is a highly problematic simulator of PG because of the low specificity of histologic findings in patients with the syndrome and its frequent response to systemic corticosteroids. Also, less than one third of patients with APS show histologic evidence of coagulopathy.[6] In contrast with most cases of APS where usually thrombocytopenia is seen,[7] our patient had an elevated platelet count. Combined treatment with oral corticosteroids, immunosuppression, acetylsalicylic acid, anticoagulation, and local measures in patients with APS and leg ulcers resembling PG has been tried, with success.[8] Our patient responded to anticoagulation with warfarin alone. Our case had an atypical presentation in that the initial feature was painful necrotic ulcers over the legs that resembled pyoderma gangrenosum and she had no systemic manifestations. There was no history of any arterial or venous thrombosis or any abortions. Antiphospholipid syndrome can be tricky to diagnose when the cutaneous lesions are atypical. Nonetheless, it is very important to pin down this syndrome early due to its systemic complications.
  8 in total

1.  Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases.

Authors:  Camille Francès; Suzanne Niang; Emmanuel Laffitte; Francois le Pelletier; Nathalie Costedoat; Jean Charles Piette
Journal:  Arthritis Rheum       Date:  2005-06

2.  Leg ulcers in the antiphospholipid syndrome may be considered as a form of pyoderma gangrenosum and they respond favorably to treatment with immunosuppression and anticoagulation.

Authors:  Carlos A Cañas; Carlos E Durán; Juan C Bravo; Dora E Castaño; Gabriel J Tobón
Journal:  Rheumatol Int       Date:  2010-03-28       Impact factor: 2.631

Review 3.  Skin ulcers misdiagnosed as pyoderma gangrenosum.

Authors:  Roger H Weenig; Mark D P Davis; Patrick R Dahl; W P Daniel Su
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

Review 4.  Antiphospholipid syndrome in dermatology: an update.

Authors:  Reena Rai; C Shanmuga Sekar; M Kumaresan
Journal:  Indian J Dermatol Venereol Leprol       Date:  2010 Mar-Apr       Impact factor: 2.545

Review 5.  Antiphospholipid antibody syndrome.

Authors:  Wendy Lim
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

Review 6.  Antiphospholipid syndrome.

Authors:  Sefer Gezer
Journal:  Dis Mon       Date:  2003-12       Impact factor: 3.800

Review 7.  Cutaneous manifestations of antiphospholipid syndrome: a review of the clinical features, diagnosis and management.

Authors:  Teresa Pinto-Almeida; Mónica Caetano; Madalena Sanches; Manuela Selores
Journal:  Acta Reumatol Port       Date:  2013 Jan-Mar       Impact factor: 1.290

8.  Flank ulcer in a patient with primary antiphospholipid syndrome.

Authors:  C W Lee; M H Park
Journal:  J Korean Med Sci       Date:  1999-02       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.